Paper2248508
Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.
Ueda N and 2 others. Arch Dis Child, 1990. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. Papers, record 2248508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2248508
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclophosphamide | Major topic |
| Nephrosis, Lipoid | Major topic |
| Child | |
| Dose-Response Relationship, Drug | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Prednisolone | |
| Prospective Studies | |
| Recurrence | |
| Time Factors |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 2053810 | Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. | https://conductscience.org/library/papers/2053810 |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 621614 | Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy. | J Pediatr | 1978 | https://conductscience.org/library/papers/621614 | PubMed |
| 2 | 6229699 | Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy. | N Engl J Med | 1984 | https://conductscience.org/library/papers/6229699 | PubMed |
| 3 | 3335948 | Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome. | J Pediatr | 1988 | https://conductscience.org/library/papers/3335948 | PubMed |
| 4 | 4698338 | Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome. | J Pediatr | 1973 | https://conductscience.org/library/papers/4698338 | PubMed |
| 5 | 4339533 | Long-term follow-up of children with steroid-responsive nephrotic syndrome. | J Pediatr | 1972 | https://conductscience.org/library/papers/4339533 | PubMed |
| 6 | 934751 | Cyclophosphamide in the treatment of idiopathic nephrotic syndrome. | Pediatrics | 1976 | https://conductscience.org/library/papers/934751 | PubMed |
| 7 | 4574639 | Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. | Arch Dis Child | 1973 | https://conductscience.org/library/papers/4574639 | PubMed |
| 8 | 4855503 | Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome. | J Pediatr | 1974 | https://conductscience.org/library/papers/4855503 | PubMed |
| 9 | 4425844 | Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide. | Br Med J | 1974 | https://conductscience.org/library/papers/4425844 | PubMed |
| 10 | 46019 | Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood. | Lancet | 1975 | https://conductscience.org/library/papers/46019 | PubMed |
| 11 | 1249681 | Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome. | J Pediatr | 1976 | https://conductscience.org/library/papers/1249681 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42867774 | Follow-up Outcomes of 100 Children with Frequently Relapsing and Steroid Dependent Nephrotic Syndrome Treated with Oral Cyclophosphamide: A Retrospective Cohort Study. | Indian Pediatr | 2026 | https://conductscience.org/library/papers/42867774 | PubMed |
| 39513526 | Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. | Cochrane Database Syst Rev | 2024 | https://conductscience.org/library/papers/39513526 | PubMed |
| 33786660 | Oral cyclophosphamide therapy in 100 children with steroid-sensitive nephrotic syndrome: experience from a developing country. | Pediatr Nephrol | 2021 | https://conductscience.org/library/papers/33786660 | PubMed |
| 33506028 | CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/33506028 | PubMed |
| 32297308 | Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32297308 | PubMed |
| 30121800 | Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome. | Clin Exp Nephrol | 2019 | https://conductscience.org/library/papers/30121800 | PubMed |
| 27108294 | Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children. | Clin Exp Nephrol | 2017 | https://conductscience.org/library/papers/27108294 | PubMed |
| 27054016 | Immunosuppressive therapy in children with steroid-resistant, frequently-relapsing, and steroid-dependent idiopathic nephrotic syndrome: a single center experience. | Electron Physician | 2016 | https://conductscience.org/library/papers/27054016 | PubMed |
| 25785660 | Corticosteroid therapy for nephrotic syndrome in children. | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/25785660 | PubMed |
| 25653046 | Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. | Clin Exp Nephrol | 2015 | https://conductscience.org/library/papers/25653046 | PubMed |
| 25190492 | Fertility preservation in patients receiving cyclophosphamide therapy for renal disease. | Pediatr Nephrol | 2015 | https://conductscience.org/library/papers/25190492 | PubMed |
| 22729760 | Is cyclophosphamide effective in patients with IgM-positive minimal change disease? | Pediatr Nephrol | 2012 | https://conductscience.org/library/papers/22729760 | PubMed |
| 22087198 | Complications of nephrotic syndrome. | Korean J Pediatr | 2011 | https://conductscience.org/library/papers/22087198 | PubMed |
| 21710249 | Cyclophosphamide followed by mizoribine as maintenance therapy against refractory steroid-dependent nephrotic syndrome. | Pediatr Nephrol | 2011 | https://conductscience.org/library/papers/21710249 | PubMed |
| 21399901 | Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome. | Pediatr Nephrol | 2011 | https://conductscience.org/library/papers/21399901 | PubMed |
| 21394465 | Cyclophosphamide in steroid-dependent nephrotic syndrome. | Pediatr Nephrol | 2011 | https://conductscience.org/library/papers/21394465 | PubMed |
| 19082635 | C1q nephropathy and minimal change nephrotic syndrome. | Pediatr Nephrol | 2009 | https://conductscience.org/library/papers/19082635 | PubMed |
| 16186679 | Treatment of steroid sensitive nephrotic syndrome. | Indian J Pediatr | 2005 | https://conductscience.org/library/papers/16186679 | PubMed |
| 16047223 | Long-term results of two unconventional agents in steroid-dependent nephrotic children. | Pediatr Nephrol | 2005 | https://conductscience.org/library/papers/16047223 | PubMed |
| 15968558 | Evidence-based management of steroid-sensitive nephrotic syndrome. | Pediatr Nephrol | 2005 | https://conductscience.org/library/papers/15968558 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2248508
GET https://conductscience.org/api/papers/v1/2248508/cited_by?page=2